Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01290835 · ClinicalTrials.gov registry record · NA
Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer
A NA study, sponsored by Essentia Health.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01290835: Completed NA study, sponsored by Essentia Health.
NCT01290835 is a NA study that has completed, run by Essentia Health. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01290835, a NA study, has completed, sponsored by Essentia Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if it is feasible, safe, and effective to use Cyberknife radiotherapy to deliver partial breast radiotherapy after lumpectomy.Patients meeting eligibility criteria will be invited to participate. Adjuvant radiotherapy will be delivered using CyberKnife radiotherapy using twice daily sessions for five days for a total of ten sessions. Short-term and long-term toxicity will be assessed as well as Tumor control and site of failure (if any).
Primary Outcome
Subjects will undergo a treatment plan for partial breast irradiation with cyberknife. Feasibility will be determined by monitoring the number of potential eligible subjects enrolled that can be treated while also respecting normal tissue tolerances.
Interventions
- RADIATION Stereotactic radiotherapy delivered by CyberKnife
- RADIATION stereotactic radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-06 |
| Est. Completion | 2025-08 |
| Phase | NA |
What the finished NCT01290835 record still lists
NCT01290835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Stereotactic radiotherapy delivered by CyberKnife is the first listed.
NCT01290835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01290835 about?
NCT01290835 is a clinical study titled "Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer". The purpose of this study is to determine if it is feasible, safe, and effective to use Cyberknife radiotherapy to deliver partial breast radiotherapy after lumpectomy.Patients meeting eligibility criteria will be invited to participate. Adjuvant radiotherapy will be delivered using CyberKnife radio...
What is the current status of trial NCT01290835?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-06. Estimated completion is 2025-08.
What interventions are being tested in trial NCT01290835?
The interventions under investigation include: Stereotactic radiotherapy delivered by CyberKnife (RADIATION), stereotactic radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT01290835?
This trial is sponsored by Essentia Health, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01290835's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia